Search company, investor...

Predict your next investment

Investments

2

Portfolio Exits

1

About Corridor Venture Partners

Headquarters Location

Want to inform investors similar to Corridor Venture Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Corridor Venture Partners Investments

2 Investments

Corridor Venture Partners has made 2 investments. Their latest investment was in ClearCount Medical Solutions as part of their Debt - II on October 10, 2012.

CBI Logo

Corridor Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/16/2012

Debt - II

ClearCount Medical Solutions

$0.3M

No

7/22/2011

Debt

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/16/2012

7/22/2011

Round

Debt - II

Debt

Company

ClearCount Medical Solutions

Subscribe to see more

Amount

$0.3M

$99M

New?

No

Subscribe to see more

Co-Investors

Sources

0

Corridor Venture Partners Portfolio Exits

1 Portfolio Exit

Corridor Venture Partners has 1 portfolio exit. Their latest portfolio exit was ClearCount Medical Solutions on January 01, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/1/2014

Acquired

$99M

1

Date

1/1/2014

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.